Cenobamate Shows Stronger Real-World Seizure Control - Top-Institutions - MDSpire

Cenobamate Shows Stronger Real-World Seizure Control

Large retrospective analysis highlights differences in seizure control, retention, and adverse effects among newer agents

  • By

  • Henry Thomas

  • March 4, 2026

  • 2 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic Epilepsy Center
    Cleveland Clinic Epilepsy Center

    Cleveland, OH

    Key Differentiators

    • Neurology
    • Epilepsy
    • Clinical Research

  • #2

    Massachusetts General Hospital (MGH) Epilepsy Service
    Massachusetts General Hospital (MGH) Epilepsy Service

    Boston, MA

    Key Differentiators

    • Neurology
    • Epilepsy
    • Neuropharmacology

  • #3

    Johns Hopkins Hospital Epilepsy Center
    Johns Hopkins Hospital Epilepsy Center

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Epilepsy
    • Clinical Neurophysiology

  • #4

    University of California, San Francisco (UCSF) Epilepsy Center
    University of California, San Francisco (UCSF) Epilepsy Center

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Epilepsy
    • Clinical Research

  • #5

    Mayo Clinic Epilepsy Center
    Mayo Clinic Epilepsy Center

    Rochester, MN

    Key Differentiators

    • Neurology
    • Epilepsy
    • Neuroscience Research

Original Source(s)

Cenobamate Shows Stronger Real-World Seizure Control

  • by Henry Thomas

  • March 4, 2026

Related Content

New insights from MRI-guided laser interstitial thermal therapy for refractory epilepsy: a state-of-the-art overview

Hospital Admission May Raise Health Care Spending in Dementia

Quasi-experimental analysis of nearly 900,000 emergency department visits found no evidence of lower mortality among admitted patients.

Postop Pain Differs by Vitamin D Status

Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.